Certified by Founder Lodge
Illumina Ventures
United States - San Francisco, CA
INVESTOR
1 Disclosed Funding Rounds $225,000,000
55 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Illumina Ventures is an independently managed firm focused on early-stage companies that are pioneering new applications of genomics and enabling precision medicine.
We invest in life sci
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| April, 28 ,2023 | Series C | Undisclosed Amount |
| Company | Date | Round | Raised |
|---|---|---|---|
 Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
 Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
 Pluton Biosciences |
May, 25 ,2023 | Series A | $16,500,000 |
 Broken String Biosciences |
September, 19 ,2023 | Series A | $15,000,000 |
 Iambic Therapeutics |
October, 06 ,2023 | Series B | $100,000,000 |
 Tagomics |
February, 22 ,2024 | Unknown | $8,495,419 |
 Actym Therapeutics, Inc. |
October, 20 ,2023 | Series A | $59,500,000 |
 Delfi Diagnostics |
July, 18 ,2022 | Series B | $225,000,000 |
 Predicta Biosciences |
July, 17 ,2024 | Seed | $5,200,000 |
 Pattern Bioscience |
April, 28 ,2023 | Series C | $28,700,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| Broken String Biosciences |
September, 19 ,2023 | Series A | $15,000,000 |
| Actym Therapeutics, Inc. |
October, 20 ,2023 | Series A | $59,500,000 |
| Iambic Therapeutics |
October, 06 ,2023 | Series B | $100,000,000 |
| Tagomics |
February, 22 ,2024 | Unknown | $8,495,419 |
| Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
| Tagomics |
February, 22 ,2024 | Unknown | $8,495,419 |
| Pluton Biosciences |
May, 25 ,2023 | Series A | $16,500,000 |
| Broken String Biosciences |
September, 19 ,2023 | Series A | $15,000,000 |
| Iambic Therapeutics |
October, 06 ,2023 | Series B | $100,000,000 |
| Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
| Actym Therapeutics, Inc. |
October, 20 ,2023 | Series A | $59,500,000 |
| Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
| Predicta Biosciences |
July, 17 ,2024 | Seed | $5,200,000 |
| Predicta Biosciences |
July, 17 ,2024 | Seed | $5,200,000 |
| Lightcast Discovery |
August, 18 ,2023 | Series B | $49,000,000 |
| Iambic Therapeutics |
October, 06 ,2023 | Series B | $100,000,000 |
| Actym Therapeutics, Inc. |
October, 20 ,2023 | Series A | $59,500,000 |
 Integrated Biosciences, Inc. |
October, 04 ,2024 | Seed | $17,000,000 |
| Tagomics |
February, 22 ,2024 | Unknown | $8,495,419 |
| Predicta Biosciences |
July, 17 ,2024 | Seed | $5,200,000 |
| Tagomics |
February, 22 ,2024 | Unknown | $8,495,419 |
 Infinity Bio, Inc. |
June, 19 ,2025 | Series A | $8,000,000 |
| Broken String Biosciences |
September, 19 ,2023 | Series A | $15,000,000 |
| Actym Therapeutics, Inc. |
October, 20 ,2023 | Series A | $59,500,000 |
| Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
| Tagomics |
February, 22 ,2024 | Unknown | $8,495,419 |
| Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
| Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
| Predicta Biosciences |
July, 17 ,2024 | Seed | $5,200,000 |
| Predicta Biosciences |
July, 17 ,2024 | Seed | $5,200,000 |
| Iambic Therapeutics |
October, 06 ,2023 | Series B | $100,000,000 |
| Integrated Biosciences, Inc. |
October, 04 ,2024 | Seed | $17,000,000 |
| Integrated Biosciences, Inc. |
October, 04 ,2024 | Seed | $17,000,000 |
| Infinity Bio, Inc. |
June, 19 ,2025 | Series A | $8,000,000 |
| Predicta Biosciences |
July, 17 ,2024 | Seed | $5,200,000 |
 NuCicer |
August, 06 ,2025 | Series A | $11,500,000 |
| Infinity Bio, Inc. |
June, 19 ,2025 | Series A | $8,000,000 |
| Actym Therapeutics, Inc. |
October, 20 ,2023 | Series A | $59,500,000 |
| Tagomics |
February, 22 ,2024 | Unknown | $8,495,419 |
| Attovia Therapeutics |
May, 14 ,2024 | Series B | $105,000,000 |
| Predicta Biosciences |
July, 17 ,2024 | Seed | $5,200,000 |
| Integrated Biosciences, Inc. |
October, 04 ,2024 | Seed | $17,000,000 |
| Infinity Bio, Inc. |
June, 19 ,2025 | Series A | $8,000,000 |
| NuCicer |
August, 06 ,2025 | Series A | $11,500,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Helex | $3,500,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
catalyx space | $5,400,000 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
